Antibody Functional Profiling

About CellChorus

CellChorus is a private, early-stage biotech company founded in 2019 that has developed a unique AI-powered platform for dynamic single-cell functional analysis. Its core technology, TIMING™, visualizes and quantifies the behavior of thousands of individual cells in parallel, providing insights into cell therapy potency, antibody function, and immune response that are missed by conventional bulk or static single-cell methods. The company operates primarily as a technology platform and services provider, supporting pharmaceutical and biotech clients in preclinical research, candidate selection, and manufacturing consistency. CellChorus is positioned to address critical bottlenecks in immunotherapy development by delivering high-content, single-cell kinetic data.

Therapeutic Areas